homovanillic acid has been researched along with benzyloxycarbonyl-isoleucyl-glutamyl(o-tert-butyl)-alanyl-leucinal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Desbarats, J; Kouassi, E; Landau, AM; Siegrist-Johnstone, R | 1 |
| Araki, T; Kadoguchi, N; Kato, H; Kimoto, H; Yano, R | 1 |
2 other study(ies) available for homovanillic acid and benzyloxycarbonyl-isoleucyl-glutamyl(o-tert-butyl)-alanyl-leucinal
| Article | Year |
|---|---|
Proteasome inhibitor model of Parkinson's disease in mice is confounded by neurotoxicity of the ethanol vehicle.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Central Nervous System Depressants; Chromatography, High Pressure Liquid; Cysteine Proteinase Inhibitors; Disease Models, Animal; Dopamine; Ethanol; Homovanillic Acid; Mice; Mice, Inbred C57BL; Neurons; Oligopeptides; Parkinson Disease; Time Factors; Tyrosine 3-Monooxygenase | 2007 |
Failure of acute administration with proteasome inhibitor to provide a model of Parkinson's disease in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Cysteine Proteinase Inhibitors; Disease Models, Animal; Dopamine; Drug Administration Schedule; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neurons; Neurotoxins; Oligopeptides; Parkinsonian Disorders; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Reproducibility of Results; Time Factors; Tyrosine 3-Monooxygenase | 2008 |